![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » KENYA, TANZANIA CLASH OVER DRUG IMPORT TARIFFS
KENYA, TANZANIA CLASH OVER DRUG IMPORT TARIFFS
August 31, 2005
Tanzania's drug industry has
further criticised Kenya's decision to remove import tariffs on pharmaceutical
products. Kenya, Uganda and Tanzania together comprise the East African Community
(EAC) customs union. The three countries had agreed to levy a 10% tariff on
imported drugs, in order to stimulate domestic production in the region, which
is home to roughly 90mn people.
Kenya had previously charged no tax on imported medicines, and the government
decided to revert to this policy in April 2005, reportedly after heavy lobbying
by local pharmaceutical interests. The Tanzanian Private Sector Foundation (TSPF)
claims that investment in the country's drug sector totalled TZS20bn (US$17.71mn)
in 2004. Tanzanian business groups are now considering suing Kenya for breaching
customs rules.
The East African drug market is worth around US$300mn, although there are few
domestic producers. Industry sources are also concerned that the removal of
the 10% tax could lead to 'dumping' by low-cost Indian and Chinese exporters.
The EAC is planning to form a common market in 2007, with a monetary union scheduled
for 2009. However, continual disagreements over tariff rates and other economic
issues threaten to derail the plans.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct